About us
SOMAPHARM supplies innovative medical products for surgical departments and emergency medicine.
Based on our more than 30 years of experience, SOMAPHARM plans to become one of the leading providers of innovative medical technology within the next three to five years with new management and new investments.
To this end, an Europe-wide expansion is planned with new, groundbreaking technologies in the fields of Surgery and Intensive Care Healthcare.
Our products shall be launched on the global stage after clinical studies and the corresponding approvals.
Advisory board
Prof. Dr. med.
A. Mendelowitsch
Neurosurgeon FMH
Prof. Dr. med. Aminadav Mendelowitsch is a specialist in neurosurgery FMH and a specialist in cerebral vascular surgery, brain tumors and spinal surgery.
He studied medicine in Basel and Baltimore and completed his training as a neurosurgeon in Basel, Bern and Washington D.C. He has specialized in particular in the areas of cerebrovascular surgery (treatment of aneurysms and vascular malformations as well as cerebral bypass surgery), brain tumors and spinal surgery.
In 2004 he was co-founder of the Cranio-Faciales-Centrum (CFC) in the Hirslanden Klinik Aarau. Since 2006 he has been head of the neurosurgery department at the Hirslanden Klinik Aarau and co-head of the Neurocenter Aarau since 2017.
Prof. Mendelowitsch is the author of numerous scientific publications. He is the Swiss delegate for the World Federation of Neurosurgical Societies (WFNS) and a member of the Swiss Society for Neurosurgery (SGNC), the Swiss Neurological Society (SNG), the Swiss Society for Neuroscience (SSN), the European Skull Base Society (ESBS) and the Congress on Neurological Surgeons (CNS).
Prof. Dr. med.
Alexander Bachmann
Prof. Bachmann was the head physician of the Urological Clinic of the University Hospital Basel for many years (2006-2016). One of his clinical focuses is minimally invasive treatment methods for prostate and kidney surgery.
From 2016-2018 he was CEO and Medical Director of alta-uro in Basel. He is also one of the world’s first experts in laser treatment of the prostate (2002), in particular greenlight laser surgery for benign prostate enlargement, which is now regarded as the “standard surgical method” in the USA.
He has published or contributed to more than 200 scientific articles and numerous book chapters.
He is Professor of Urology at the University of Basel and Executive Member of the European Society of UroTechnology (ESUT) of the European Society for Urology (EAU), whose chairman position he previously held for the topic of “lower urinary tract”. In addition, he was for over 10 years in the working group before laparoscopy, da Vinci and Endourology of the German Society for Urology (DGU), Adjunct Professor at MedUni Vienna, Shanghai International Medical Center and Professor Extraordinaire at Stellenbosch University. Prof. Bachmann was the head of the “Goliath Study” (XPS-Greenlight-Laser versus TURP), one of the largest RCTs in the field of benign prostate enlargement.
History
Foundation of SOMAPHARM AG.
Import of Viagra into Switzerland
Takeover of the company by the Weisser brothers
Development of your own innovation - NOMA I
Do you have any questions about Somapharm AG and would like to know more about our products ? Contact request
Client testimonials
First impressions count
Philosophy
Innovation
We are active on the market with new products and product ideas to assist users in clinics, practices and research to effectively and optimally care for their patients.
Reliability
We use all of our resources to meet the demands and needs of our customers. We use all our resources to meet our customers’ needs and requirements. Reliability towards you is our highest priority.
Transparency
Our price structure is adapted to the healthcare market’s current financing practices. We value the greatest possible openness and transparency in our business relationships. Our own nationwide distribution network makes us the ideal partner for the healthcare sector.
Changes in today’s market are our motivation and the individual needs of our customers are our challenge.
Continuity
The rapid changes in today’s market are a major challenge for our performance. We therefore rely on our highly motivated employees, who have a high level of specialist and advisory skills through constant training and further education.
Are you interested in further studies by Somapharm AG?
Are you interested in further studies by Somapharm AG?
Client testimonials
First impressions count
Our Clients
